2005). Therefore, TFR2 genotyping should be considered in suspected hemochromatosis patients negative for HFE mutations and with early-onset of iron overload. In addition, it should be performed in juvenile HH forms without mutations in the HAMP or HFE2 genes. This evidence concerns the gene TFR2 and hemochromatosis.